3,6-dimethylaminodibenzopyriodonium citrate: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 197236 |
| MeSH ID | M0157461 |
| Synonym |
|---|
| i 65 |
| iodinium-heterocycl-65 citrate |
| 3,6-dimethamidodibenzopyriodonium citrate |
| 10h-dibenz(b,e)iodinium, 3,7-bis(dimethylamino)-, salt with 2-hydroxy-1,2,3-propanetricarboxylic acid (1:1) |
| i-65 |
| 3,6-dimethylaminodibenzopyriodonium citrate |
| 111950-71-1 |
| DTXSID20149788 |
| 3-carboxy-3,5-dihydroxy-5-oxopentanoate;5-n,5-n,13-n,13-n-tetramethyl-2-iodoniatricyclo[8.4.0.03,8]tetradeca-1(10),3(8),4,6,11,13-hexaene-5,13-diamine |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 4 (57.14) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.32) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||